Real-World Experience With CMV inSIGHT T Cell Immunity Testing in High-Risk Kidney and Pancreas Transplant Recipients.

Jillian L DescourouezJeannina A SmithChristopher M SaddlerDidier A MandelbrotJon S OdoricoMargaret R Jorgenson

Published in: The Annals of pharmacotherapy (2023)

The data obtained from the TCIP are not static, immune control of CMV in latency can change and must be evaluated in clinical context. Timing of TCIP after transplant is significant, and patient-specific factors remain important to assess the likelihood of CMV in each unique patient-specific scenario. A CMV stewardship program can aid in application and interpretation of results.

Keyphrases

electronic health record
quality improvement
big data
machine learning
deep learning
data analysis